Drs. Jason Kim and Steven Weissbart from the Women’s Pelvic Health and Continence Center at Stony Brook University Hospital have successfully conducted one of the first Glean Urodynamics procedures in the United States using Bright Uro’s ambulatory urodynamic system. This marks a significant advancement in diagnosing bladder function for approximately 17 million Americans experiencing daily bladder control issues.
The Glean system differs from traditional urodynamic studies by allowing real-time data collection in an ambulatory setting, providing a more natural experience for patients. It offers wireless, catheter-free monitoring of bladder pressure, enhancing diagnostic accuracy and patient comfort.
Dr. Jason Kim, who serves as the national principal investigator for the FDA-approved trial of the Glean system, noted that “this new technology marks a major step forward in patient-centered care by providing a more physiologic, less invasive approach to urodynamic testing.”
Stony Brook University Hospital is now the second site nationwide and the first on the East Coast to adopt this technology, continuing its leadership in advancing care for patients with pelvic floor disorders and lower urinary tract symptoms.
